Picture of Biolife Sciences logo

BLFE Biolife Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Biolife Sciences, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

C2006
November 30th
2007
November 30th
2010
November 30th
2011
November 30th
2012
November 30th
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSBARSARS10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.291-2.051.72-0.293-0.202
Depreciation
Amortisation
Non-Cash Items0.1351.080.0410.2270.153
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0080.54200.0130.013
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-0.083-0.2851.76-0.04-0.037
Capital Expenditures-0.0250
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.510.04-0.54500
Acquisition of Business
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-1.530.04-0.54500
Financing Cash Flow Items-0.216-0.072-1.530.0370.034
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.50.577-1.220.0380.034
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.120.3310.004-0.002-0.003

Or unlock with your email

Or unlock with your email